[go: up one dir, main page]

GB8601389D0 - Treating pharmaceutical dosage forms - Google Patents

Treating pharmaceutical dosage forms

Info

Publication number
GB8601389D0
GB8601389D0 GB868601389A GB8601389A GB8601389D0 GB 8601389 D0 GB8601389 D0 GB 8601389D0 GB 868601389 A GB868601389 A GB 868601389A GB 8601389 A GB8601389 A GB 8601389A GB 8601389 D0 GB8601389 D0 GB 8601389D0
Authority
GB
United Kingdom
Prior art keywords
dosage forms
pharmaceutical dosage
treating pharmaceutical
treating
forms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB868601389A
Other versions
GB2170104A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/696,955 external-priority patent/US4600645A/en
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of GB8601389D0 publication Critical patent/GB8601389D0/en
Publication of GB2170104A publication Critical patent/GB2170104A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
GB08601389A 1985-01-30 1986-01-21 Coated pharmaceutical dosage forms Withdrawn GB2170104A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69694585A 1985-01-30 1985-01-30
US06/696,955 US4600645A (en) 1985-01-31 1985-01-31 Process for treating dosage forms

Publications (2)

Publication Number Publication Date
GB8601389D0 true GB8601389D0 (en) 1986-02-26
GB2170104A GB2170104A (en) 1986-07-30

Family

ID=27105903

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08601389A Withdrawn GB2170104A (en) 1985-01-30 1986-01-21 Coated pharmaceutical dosage forms

Country Status (1)

Country Link
GB (1) GB2170104A (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU85943A1 (en) * 1985-06-12 1987-01-13 Galephar PHARMACEUTICAL TABLETS FOR THE EASY ADMINISTRATION OF PELLETS, THEIR PREPARATION AND THEIR USE
US4931285A (en) * 1988-04-28 1990-06-05 Alza Corporation Aqueous based pharmaceutical coating composition for dosage forms
US5683719A (en) * 1990-11-22 1997-11-04 British Technology Group Limited Controlled release compositions
GB9025372D0 (en) * 1990-11-22 1991-01-09 Nat Res Dev Pharmaceutical dosage forms
JPH06504276A (en) * 1991-01-03 1994-05-19 グラクソ、カナダ、インコーポレーテッド Manufacturing method for solid preparations
US5958459A (en) * 1991-12-24 1999-09-28 Purdue Pharma L.P. Opioid formulations having extended controlled released
US5273760A (en) * 1991-12-24 1993-12-28 Euroceltigue, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
US5472712A (en) * 1991-12-24 1995-12-05 Euroceltique, S.A. Controlled-release formulations coated with aqueous dispersions of ethylcellulose
US5681585A (en) * 1991-12-24 1997-10-28 Euro-Celtique, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
US7740881B1 (en) 1993-07-01 2010-06-22 Purdue Pharma Lp Method of treating humans with opioid formulations having extended controlled release
IL110014A (en) 1993-07-01 1999-11-30 Euro Celtique Sa Solid controlled-release oral dosage forms of opioid analgesics
WO1999001111A1 (en) 1997-07-02 1999-01-14 Euro-Celtique, S.A. Stabilized sustained release tramadol formulations
ES2221370T3 (en) 1998-04-03 2004-12-16 Egalet A/S COMPOSITION OF CONTROLLED RELEASE.
RU2230556C2 (en) 1999-10-29 2004-06-20 Эро-Селтик, С.А. Hydrocodon preparative sustained-release formulations
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
WO2002036099A1 (en) 2000-10-30 2002-05-10 Euro-Celtique S.A. Controlled release hydrocodone formulations
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
UA81224C2 (en) 2001-05-02 2007-12-25 Euro Celtic S A Dosage form of oxycodone and use thereof
US20040253310A1 (en) 2001-09-21 2004-12-16 Gina Fischer Morphine polymer release system
US20040234602A1 (en) 2001-09-21 2004-11-25 Gina Fischer Polymer release system
US20040151772A1 (en) 2002-11-08 2004-08-05 Egalet A/S Controlled release carvedilol compositions
ES2360102T3 (en) 2003-03-26 2011-05-31 Egalet A/S SYSTEM FOR CONTROLLED RELEASE OF MORPHINE.
JP4989217B2 (en) 2003-03-26 2012-08-01 エガレット エイ/エス Matrix composition for controlled delivery of drug substance
US8821928B2 (en) 2007-06-04 2014-09-02 Egalet Ltd. Controlled release pharmaceutical compositions for prolonged effect
NZ594207A (en) 2009-02-06 2013-03-28 Egalet Ltd Immediate release composition resistant to abuse by intake of alcohol
NZ603579A (en) 2009-06-24 2014-02-28 Egalet Ltd Controlled release formulations
JP2015521988A (en) 2012-07-06 2015-08-03 イガレット・リミテッド Abuse-preventing pharmaceutical composition for controlled release

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3242051A (en) * 1958-12-22 1966-03-22 Ncr Co Coating by phase separation
US3487138A (en) * 1966-11-23 1969-12-30 Merck & Co Inc Process for preparing a delayed release medicinal tablet
IE55745B1 (en) * 1983-04-06 1991-01-02 Elan Corp Plc Sustained absorption pharmaceutical composition
PH18946A (en) * 1983-04-21 1985-11-14 Elan Corp Plc Controlled absorption pharmaceutical composition

Also Published As

Publication number Publication date
GB2170104A (en) 1986-07-30

Similar Documents

Publication Publication Date Title
GB8601389D0 (en) Treating pharmaceutical dosage forms
PH22751A (en) Process for treating dosage forms
GB2210266B (en) Dosage form
GB8608149D0 (en) Furazolidine dosage form
GB8626894D0 (en) Dosage device
PT83075A (en) Pharmaceutical dosage unit
GB8615043D0 (en) Solid stable dosage forms
DE3565468D1 (en) Drug administering apparatus
GB8513369D0 (en) Treatment
GB8515845D0 (en) Treatment
GB8501488D0 (en) Treatment
GB8607178D0 (en) Dosage means
ZA86252B (en) Coated dosage forms
GB8708225D0 (en) Dosage form
GB2171305B (en) Pharmaceutical combinations
GB8620716D0 (en) Medicament
ZA87111B (en) Pharmaceutical dosage form
GB8513367D0 (en) Treatment
GB8509039D0 (en) Treatment
IE851153L (en) Transdermal dosage form
IE861995L (en) Pharmaceutical dosage unit
IE853321L (en) Process for treating dosage forms
IE883718L (en) Pharmaceutical dosage units for treating climacteric¹complaints
GB8529502D0 (en) Pharmaceutical mixtures
GB8509889D0 (en) Pharmaceutical mixtures

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)